Evidence map›Paper›PMID 41217945›Full record

ArticleNucleic acids research2026

PersADE: a database of personalized adverse drug events and their underlying molecular mechanisms.

Zhuohang Yu, Yimeng Wang, Yintao Zhang, Ying Zhou, Xiaoxiao Hu, Lesang Shen, Chao Ni, Ping Xing, Fengbo Huang, Tingting Fu and 4 more

Erratum issuedAbstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Zhuohang YuSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Yimeng WangCollege of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.
Yintao ZhangCollege of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0002-5263-3438
Ying ZhouSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.ORCID 0009-0007-3875-3496
Xiaoxiao HuSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Lesang ShenSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Chao NiSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Ping XingSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Fengbo HuangSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Tingting FuCollege of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China.ORCID 0009-0007-6486-2426
Lianyi HanDepartment of Dermatology, Huashan Hospital, Fudan University, Shanghai 200040, China.ORCID 0000-0002-6364-7843
Jian HuangSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Haibin DaiSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
Feng ZhuSecond Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.

Funding

Information Technology Center and State Key Lab of CAD&CG of Zhejiang UniversityNational Key R&D Program of P.R. China 2024YFA1307503National Natural Science Foundation of P.R. China 22220102001National Natural Science Foundation of P.R. China 82373790National Natural Science Foundation of P.R. China 82503970National Natural Science Foundation of P.R. China 82504672Natural Science Foundations of Zhejiang RG25H300001
6 · The paper itself

Abstract

As a major burden on global healthcare systems, adverse drug events (ADEs) result in significant morbidity, mortality, and healthcare resource consumption. With the rapid advances in precision medicine, personalized ADEs and their molecular mechanisms are important components of drug repurposing and drug safety improvement. Thus, extensive studies have been conducted to collect valuable information on personalized ADEs, but no database has yet been available to provide such data. In this work, PersADE, a database aiming to provide personalized drug adverse events and their molecular mechanisms, was constructed. It integrated 4 061 772 personalized drug-ADE associations, 31 756 protein-ADE associations, and 108 677 drug-protein interactions, with a particular emphasis on off-target effects. The uniqueness of these data lies in (a) providing demographic characteristics, disease context and drug administration parameters associated with ADEs, enabling stratification of drug-ADE associations; (b) systematically integrating interactions among drugs, human proteins and ADEs, describing the mechanistic insights. Given the growing global focus on precision medicine, PersADE is highly anticipated to significantly impact studies on personalized ADEs and mechanistic explorations by providing researchers and clinicians with evidence-based tools. It is now freely accessible at: https://idrblab.org/PersADE.

Indexed as

Databases, FactualDrug-Related Side Effects and Adverse ReactionsPrecision MedicineDrug RepositioningHumans

Identifiers

PMID41217945
PMCPMC12807753

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.